Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Treating Hyperexcitability in Alzheimer's Disease With Levetiracetam to Improve Brain Function and Cognition
Authors not listed
Beth Israel Deaconess Medical Center · 2019
Abstract
The aim of this study is to explore the relationship between cortical hyperexcitability, abnormalities of brain network function, and cognitive dysfunction in human patients with AD and whether administration of the antiepileptic medication levetiracetam (LEV) normalizes these measures and improves cognition.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Anonymous. (2019). Treating Hyperexcitability in Alzheimer's Disease With Levetiracetam to Improve Brain Function and Cognition. <em>Beth Israel Deaconess Medical Center</em>. https://clinicaltrials.gov/study/NCT03875638
Vancouver
Anonymous. Treating Hyperexcitability in Alzheimer's Disease With Levetiracetam to Improve Brain Function and Cognition. Beth Israel Deaconess Medical Center. 2019.
BibTeX
@misc{anon2019Treati,
title = {Treating Hyperexcitability in Alzheimer's Disease With Levetiracetam to Improve Brain Function and Cognition},
author = {Anonymous},
journal = {Beth Israel Deaconess Medical Center},
year = {2019},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Inmune Bio, Inc. 2022
Open access · US-GOV
A Randomized, Placebo-Controlled, Double-Blind Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
Assistance Publique - Hôpitaux de Paris 2007
Open access · US-GOV
A Multicenter Study to Assess Differences Between Circulating Levels of IGF-I and IGFBP-3 in Patients With Sporadic Late-onset Alzheimer's Disease and Control Elderly Subjects.
Hillel Grossman 2018
Open access · US-GOV
Phase II Grape Seed Extract as Anti-Oligomerization Agent in Alzheimer's Disease
Journal of the Neurological Sciences 2013
Citation only
Telomere length distribution of circulating leukocytes in patients with Alzheimer's disease
The University of Texas Health Science Center at San Antonio 2017
Open access · US-GOV
The Effects of NAD on Brain Function and Cognition
Sanofi 2008
Open access · US-GOV